We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

824 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 204 funds opening new positions, 241 increasing their positions, 284 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more funds holding in top 10

Funds holding in top 10: 18 → 46 (+28)

155% more first-time investments, than exits

New positions opened: 204 | Existing positions closed: 80

38% more capital invested

Capital invested by funds: $22.6B → $31.3B (+$8.67B)

28% more call options, than puts

Call options by funds: $559M | Put options by funds: $436M

17% more funds holding

Funds holding: 707 → 824 (+117)

15% less repeat investments, than reductions

Existing positions increased: 241 | Existing positions reduced: 284

Holders
824
Holders Change
+117
Holders Change %
+16.55%
% of All Funds
14.58%
Holding in Top 10
46
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+155.56%
% of All Funds
0.81%
New
204
Increased
241
Reduced
284
Closed
80
Calls
$559M
Puts
$436M
Net Calls
+$123M
Net Calls Change
+$163M

Top Buyers

1
PCM
Pentwater Capital Management
Florida
+$380M
2
FCM
Farallon Capital Management
California
+$289M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$271M
4
HI
HBK Investments
Texas
+$221M
5
Millennium Management
Millennium Management
New York
+$211M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$451M
2
Ameriprise
Ameriprise
Minnesota
-$353M
3
O
OrbiMed
New York
-$259M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$203M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$194M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
326
Athos Capital
Hong Kong
$3.28M +$2.7M +21,000 New
ISL
327
Ingalls & Snyder LLC
New York
$3.19M +$2.62M +20,410 New
MPM
328
Meritage Portfolio Management
Kansas
$3.17M +$2.6M +20,259 New
BPC
329
Banque Pictet & Cie
Switzerland
$3.16M -$1.3M -10,089 -33%
SMC
330
S. Muoio & Co
New York
$3.13M +$2.57M +20,000 New
WAM
331
Wolverine Asset Management
Illinois
$3.12M +$2.24M +17,440 +682%
APF
332
Alaska Permanent Fund
Alaska
$3.11M – – –
SAM
333
Securian Asset Management
Minnesota
$3.08M -$56.5K -440 -2%
NB
334
Norinchukin Bank
Japan
$3.03M -$15.2K -118 -0.6%
HA
335
Havens Advisors
New York
$3.01M +$2.48M +19,285 New
CIC
336
Cornercap Investment Counsel
Georgia
$3.01M -$275K -2,137 -7%
LOAMU
337
Lombard Odier Asset Management (USA)
New York
$2.97M +$2.44M +19,000 New
SCM
338
Soleus Capital Management
Connecticut
$2.96M -$1.43M -11,139 -37%
BNP Paribas Asset Management
339
BNP Paribas Asset Management
France
$2.89M -$41.8K -325 -2%
SCM
340
Shelton Capital Management
Colorado
$2.79M – – –
AWM
341
Avitas Wealth Management
California
$2.78M +$2.29M +17,799 New
BBNA
342
Bremer Bank National Association
Minnesota
$2.75M -$31.2K -243 -1%
CC
343
Centiva Capital
New York
$2.73M +$2.25M +17,500 New
PTC
344
Private Trust Company
Ohio
$2.73M -$62.8K -489 -3%
Vontobel Holding
345
Vontobel Holding
Switzerland
$2.72M +$2.26M +17,607 New
Public Sector Pension Investment Board (PSP Investments)
346
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.69M -$1.23M -9,590 -36%
Two Sigma Investments
347
Two Sigma Investments
New York
$2.59M +$934K +7,268 +78%
SDIC
348
South Dakota Investment Council
South Dakota
$2.53M -$154K -1,200 -7%
GIM
349
Guild Investment Management
California
$2.53M +$2.08M +16,200 New
AA
350
AlphaMark Advisors
Kentucky
$2.5M -$1.18M -9,145 -36%
12 13
14
15 16

ALXN Hedge Fund Activity: Q4 2020 in Review

824 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q4 2020, worth a combined $31.3B — up 38% from $22.6B a quarter earlier.

Buyers outnumbered sellers: 204 funds opened new ALXN positions and 80 closed out — a net gain of 124 holders — while 241 added to existing stakes and 284 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $380M. The largest seller was Fidelity Investments, cutting an estimated $451M.

  • 824 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q4 2020, up from 707 in Q3 2020.
  • Funds reported $31.3B of Alexion Pharmaceuticals stock for Q4 2020, up 38% quarter-over-quarter.
  • 204 funds opened new Alexion Pharmaceuticals positions in Q4 2020 and 80 closed out, a net change of +124 holders.
  • The largest Alexion Pharmaceuticals buyer in Q4 2020 was Pentwater Capital Management, an estimated $380M added.
  • The largest Alexion Pharmaceuticals seller in Q4 2020 was Fidelity Investments, an estimated $451M sold.

Based on aggregated 13F filings for Q4 2020.